{
  "main_header": {
    "sid": 10038983,
    "name": "Crop Life Scienc",
    "stock_name": "Crop Life Scienc",
    "full_name": "Crop Life Science Ltd",
    "name_url": "stocks-analysis/crop-life-scienc",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "45.20",
    "chg": 0.2,
    "chgp": "0.44%",
    "dir": 1,
    "prev_price": "45.00",
    "mcapval": "77.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "CLSL",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE00NH01017",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": 2000,
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/crop-life-scienc-10038983-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Crop Life Scienc falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-crop-life-scienc-fallingrising-3756937",
        "imagepath": "",
        "date": "2025-12-12 01:13:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Stock Performance Against Market Benchmarks</strong></p>\n<p>Crop Life Science's recent price movement starkly contrasts with the broader market's positive trajectory. Over the past week, the stock has declined by 9.7%, while the Sensex has marginally dipped by only 0.52%. Extending the horizon, the one-month return for Crop Life Science stands at a negative 16.39%, whereas the Sensex has gained 0.79%. Year-to-date figures further highlight this divergence, with the stock down 9.97% compared to the Sensex's robust 9.53% gain. Even over the last year, Crop Life Science has underperformed, registering a 5.64% loss against the Sensex's 5.10% rise. These figures underscore a persistent weakness in the stock relative to the broader market.</p>\n<p><strong>Technical Indicators Signal Continued Downt..."
      },
      {
        "title": "How has been the historical performance of Crop Life Scienc?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-crop-life-scienc-3695756",
        "imagepath": "",
        "date": "2025-11-13 00:38:22",
        "description": "Answer:\nThe historical performance of Crop Life Scienc shows a mixed trend in financial metrics from March 2024 to March 2025.\n\nBreakdown:\nIn the fiscal year ending March 2025, Crop Life Scienc reported net sales of 200.59 Cr, a slight increase from 198.61 Cr in the previous year. Total operating income also rose to 200.59 Cr from 198.61 Cr, while total expenditure decreased to 184.23 Cr from 185.99 Cr. This led to an operating profit (PBDIT) of 17.38 Cr, up from 14.73 Cr, reflecting an improved operating profit margin of 8.16%, compared to 6.35% in the prior year. However, profit before tax decreased to 7.80 Cr from 8.11 Cr, resulting in a profit after tax of 5.60 Cr, down from 6.02 Cr, which translates to a PAT margin of 2.79%, down from 3.03%. On the balance sheet, total assets increased to 181.71 Cr from 179.87 Cr, with total liabilities also rising to 181.71 Cr from 179.87 Cr. Shareholder's funds grew ..."
      },
      {
        "title": "Is Crop Life Scienc overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crop-life-scienc-overvalued-or-undervalued-3687859",
        "imagepath": "",
        "date": "2025-11-11 08:14:52",
        "description": "As of 10 November 2025, the valuation grade for Crop Life Science has moved from expensive to fair. This suggests that the company is now fairly valued in the market. The key ratios supporting this assessment include a PE Ratio of 13.98, an EV to EBITDA of 8.16, and a ROCE of 11.07%. \n\nIn comparison to its peers, Crop Life Science's PE Ratio is significantly lower than that of UPL, which stands at 26.58, indicating that Crop Life Science may be undervalued relative to its more expensive counterparts. Additionally, Dhanuka Agritech, which is also rated as fair, has a PE Ratio of 19.85, further emphasizing the competitive positioning of Crop Life Science within the industry. Notably, the company's stock has outperformed the Sensex over the past year, returning 11.92% compared to the Sensex's 5.91%, reinforcing the notion that it is fairly valued in the current market landscape...."
      },
      {
        "title": "Is Crop Life Scienc overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crop-life-scienc-overvalued-or-undervalued-3678215",
        "imagepath": "",
        "date": "2025-11-07 08:14:03",
        "description": "As of 6 November 2025, the valuation grade for Crop Life Science has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its key financial ratios, including a PE ratio of 13.98, an EV to EBITDA of 8.16, and a PEG ratio of 1.46. In comparison to its peers, UPL is rated fair with a PE of 41.31, while Bayer CropScience is also expensive with a PE of 36.07, highlighting that Crop Life Science's valuation is significantly lower than these competitors.\n\nGiven these metrics and the recent performance, Crop Life Science appears to be overvalued in the current market context. While it has shown a year-to-date return of 7.68%, slightly below the Sensex's return of 7.89%, the overall valuation suggests that investors may be paying a premium for the stock relative to its earnings potential and industry peers...."
      },
      {
        "title": "Is Crop Life Scienc overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crop-life-scienc-overvalued-or-undervalued-3636592",
        "imagepath": "",
        "date": "2025-10-21 08:07:45",
        "description": "As of 20 October 2025, the valuation grade for Crop Life Science has moved from expensive to fair. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 14.24, an EV to EBITDA of 8.27, and a ROCE of 11.07%. \n\nIn comparison to its peers, Crop Life Science's PE ratio is significantly lower than UPL, which has a PE of 38.35, indicating that Crop Life Science is more attractively priced relative to its earnings. Additionally, while Crop Life Science's PEG ratio stands at 1.48, it is notably lower than that of P I Industries, which is classified as very expensive with a PEG of 0.00. Recent stock performance shows that Crop Life Science has outperformed the Sensex over the past year, returning 10% compared to the Sensex's 3.98%, reinforcing its fair valuation status...."
      },
      {
        "title": "Is Crop Life Scienc overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crop-life-scienc-overvalued-or-undervalued-3633095",
        "imagepath": "",
        "date": "2025-10-20 08:09:26",
        "description": "As of 17 October 2025, the valuation grade for Crop Life Science has moved from fair to expensive, indicating that the company is currently overvalued. The key ratios reflect this assessment, with a PE ratio of 14.50, an EV to EBITDA of 8.38, and a PEG ratio of 1.51. Compared to peers, Crop Life Science's valuation appears less attractive, especially when contrasted with UPL, which has a PE ratio of 37.91 and an EV to EBITDA of 9.14, and BASF India, boasting a PE ratio of 47.93 and an EV to EBITDA of 28.64.\n\nGiven these metrics and the overall market context, Crop Life Science is deemed overvalued. Additionally, while the company has outperformed the Sensex on a year-to-date basis with a return of 11.67% compared to the Sensex's 8.73%, this does not sufficiently justify its current valuation relative to its peers in the pesticides and agrochemicals industry...."
      },
      {
        "title": "Is Crop Life Scienc overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crop-life-scienc-overvalued-or-undervalued-3631553",
        "imagepath": "",
        "date": "2025-10-19 08:09:07",
        "description": "As of 17 October 2025, the valuation grade for Crop Life Science has moved from fair to expensive, indicating that the company is currently overvalued. Key ratios include a PE Ratio of 14.50, an EV to EBITDA of 8.38, and a ROE of 8.47%. In comparison to peers, UPL is rated attractive with a PE of 37.91, while Bayer CropScience is also expensive with a PE of 38.24, highlighting that Crop Life Science's valuation is not competitive within the industry.\n\nGiven these metrics and the peer comparison, Crop Life Science appears to be overvalued. The company's recent stock performance shows a year-to-date return of 11.67%, outperforming the Sensex's 8.73%, but this does not sufficiently justify the expensive valuation relative to its peers...."
      },
      {
        "title": "Is Crop Life Scienc overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-crop-life-scienc-overvalued-or-undervalued-3630623",
        "imagepath": "",
        "date": "2025-10-18 08:08:59",
        "description": "As of 17 October 2025, the valuation grade for Crop Life Science has moved from fair to expensive. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 14.50, an EV to EBITDA of 8.38, and a ROE of 8.47%. \n\nWhen compared to its peers, Crop Life Science's PE Ratio is significantly lower than that of UPL, which stands at 37.91, indicating that Crop Life Science is not priced competitively within its industry. Additionally, Bayer CropScience has a much higher PE Ratio of 38.24, further emphasizing the overvaluation of Crop Life Science. Despite a positive year-to-date return of 11.67% compared to the Sensex's 8.73%, the overall valuation suggests that investors may be paying a premium for the stock relative to its earnings potential...."
      },
      {
        "title": "Why is Crop Life Scienc falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-crop-life-scienc-fallingrising-3575653",
        "imagepath": "",
        "date": "2025-09-26 23:32:21",
        "description": "As of 26-Sep, Crop Life Science Ltd is experiencing a decline in its stock price, currently at 56.20, which reflects a decrease of 4.3 or 7.11%. The stock has underperformed its sector by 5.03% today, and its delivery volume has significantly dropped by 54.55% compared to the 5-day average, indicating falling investor participation. In terms of returns, the stock has seen a 7.11% decline over the past week and a 3.10% decline over the past month, although it has performed positively year-to-date with a 12.06% increase. The stock is currently trading higher than its 100-day and 200-day moving averages but lower than its 5-day, 20-day, and 50-day moving averages, suggesting mixed momentum.\n\nIn the broader market context, the Sensex has also faced a decline of 2.65% over the past week and 0.23% over the past month, indicating a challenging environment for stocks in general. However, Crop Life Science's recent ..."
      }
    ],
    "total": 98,
    "sid": "10038983",
    "stock_news_url": "https://www.marketsmojo.com/news/crop-life-science-10038983"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Crop Life Scienc falling/rising?

2025-12-12 01:13:49

Stock Performance Against Market Benchmarks

Crop Life Science's recent price movement starkly contrasts with the broader market's positive trajectory. Over the past week, the stock has declined by 9.7%, while the Sensex has marginally dipped by only 0.52%. Extending the horizon, the one-month return for Crop Life Science stands at a negative 16.39%, whereas the Sensex has gained 0.79%. Year-to-date figures further highlight this divergence, with the stock down 9.97% compared to the Sensex's robust 9.53% gain. Even over the last year, Crop Life Science has underperformed, registering a 5.64% loss against the Sensex's 5.10% rise. These figures underscore a persistent weakness in the stock relative to the broader market.

Technical Indicators Signal Continued Downt...

Read More

How has been the historical performance of Crop Life Scienc?

2025-11-13 00:38:22

Answer: The historical performance of Crop Life Scienc shows a mixed trend in financial metrics from March 2024 to March 2025. Breakdown: In the fiscal year ending March 2025, Crop Life Scienc reported net sales of 200.59 Cr, a slight increase from 198.61 Cr in the previous year. Total operating income also rose to 200.59 Cr from 198.61 Cr, while total expenditure decreased to 184.23 Cr from 185.99 Cr. This led to an operating profit (PBDIT) of 17.38 Cr, up from 14.73 Cr, reflecting an improved operating profit margin of 8.16%, compared to 6.35% in the prior year. However, profit before tax decreased to 7.80 Cr from 8.11 Cr, resulting in a profit after tax of 5.60 Cr, down from 6.02 Cr, which translates to a PAT margin of 2.79%, down from 3.03%. On the balance sheet, total assets increased to 181.71 Cr from 179.87 Cr, with total liabilities also rising to 181.71 Cr from 179.87 Cr. Shareholder's funds grew ...

Read More

Is Crop Life Scienc overvalued or undervalued?

2025-11-11 08:14:52

As of 10 November 2025, the valuation grade for Crop Life Science has moved from expensive to fair. This suggests that the company is now fairly valued in the market. The key ratios supporting this assessment include a PE Ratio of 13.98, an EV to EBITDA of 8.16, and a ROCE of 11.07%. In comparison to its peers, Crop Life Science's PE Ratio is significantly lower than that of UPL, which stands at 26.58, indicating that Crop Life Science may be undervalued relative to its more expensive counterparts. Additionally, Dhanuka Agritech, which is also rated as fair, has a PE Ratio of 19.85, further emphasizing the competitive positioning of Crop Life Science within the industry. Notably, the company's stock has outperformed the Sensex over the past year, returning 11.92% compared to the Sensex's 5.91%, reinforcing the notion that it is fairly valued in the current market landscape....

Read More

Is Crop Life Scienc overvalued or undervalued?

2025-11-07 08:14:03

As of 6 November 2025, the valuation grade for Crop Life Science has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its key financial ratios, including a PE ratio of 13.98, an EV to EBITDA of 8.16, and a PEG ratio of 1.46. In comparison to its peers, UPL is rated fair with a PE of 41.31, while Bayer CropScience is also expensive with a PE of 36.07, highlighting that Crop Life Science's valuation is significantly lower than these competitors. Given these metrics and the recent performance, Crop Life Science appears to be overvalued in the current market context. While it has shown a year-to-date return of 7.68%, slightly below the Sensex's return of 7.89%, the overall valuation suggests that investors may be paying a premium for the stock relative to its earnings potential and industry peers....

Read More

Is Crop Life Scienc overvalued or undervalued?

2025-10-21 08:07:45

As of 20 October 2025, the valuation grade for Crop Life Science has moved from expensive to fair. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 14.24, an EV to EBITDA of 8.27, and a ROCE of 11.07%. In comparison to its peers, Crop Life Science's PE ratio is significantly lower than UPL, which has a PE of 38.35, indicating that Crop Life Science is more attractively priced relative to its earnings. Additionally, while Crop Life Science's PEG ratio stands at 1.48, it is notably lower than that of P I Industries, which is classified as very expensive with a PEG of 0.00. Recent stock performance shows that Crop Life Science has outperformed the Sensex over the past year, returning 10% compared to the Sensex's 3.98%, reinforcing its fair valuation status....

Read More

Is Crop Life Scienc overvalued or undervalued?

2025-10-20 08:09:26

As of 17 October 2025, the valuation grade for Crop Life Science has moved from fair to expensive, indicating that the company is currently overvalued. The key ratios reflect this assessment, with a PE ratio of 14.50, an EV to EBITDA of 8.38, and a PEG ratio of 1.51. Compared to peers, Crop Life Science's valuation appears less attractive, especially when contrasted with UPL, which has a PE ratio of 37.91 and an EV to EBITDA of 9.14, and BASF India, boasting a PE ratio of 47.93 and an EV to EBITDA of 28.64. Given these metrics and the overall market context, Crop Life Science is deemed overvalued. Additionally, while the company has outperformed the Sensex on a year-to-date basis with a return of 11.67% compared to the Sensex's 8.73%, this does not sufficiently justify its current valuation relative to its peers in the pesticides and agrochemicals industry....

Read More

Is Crop Life Scienc overvalued or undervalued?

2025-10-19 08:09:07

As of 17 October 2025, the valuation grade for Crop Life Science has moved from fair to expensive, indicating that the company is currently overvalued. Key ratios include a PE Ratio of 14.50, an EV to EBITDA of 8.38, and a ROE of 8.47%. In comparison to peers, UPL is rated attractive with a PE of 37.91, while Bayer CropScience is also expensive with a PE of 38.24, highlighting that Crop Life Science's valuation is not competitive within the industry. Given these metrics and the peer comparison, Crop Life Science appears to be overvalued. The company's recent stock performance shows a year-to-date return of 11.67%, outperforming the Sensex's 8.73%, but this does not sufficiently justify the expensive valuation relative to its peers....

Read More

Is Crop Life Scienc overvalued or undervalued?

2025-10-18 08:08:59

As of 17 October 2025, the valuation grade for Crop Life Science has moved from fair to expensive. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 14.50, an EV to EBITDA of 8.38, and a ROE of 8.47%. When compared to its peers, Crop Life Science's PE Ratio is significantly lower than that of UPL, which stands at 37.91, indicating that Crop Life Science is not priced competitively within its industry. Additionally, Bayer CropScience has a much higher PE Ratio of 38.24, further emphasizing the overvaluation of Crop Life Science. Despite a positive year-to-date return of 11.67% compared to the Sensex's 8.73%, the overall valuation suggests that investors may be paying a premium for the stock relative to its earnings potential....

Read More

Why is Crop Life Scienc falling/rising?

2025-09-26 23:32:21

As of 26-Sep, Crop Life Science Ltd is experiencing a decline in its stock price, currently at 56.20, which reflects a decrease of 4.3 or 7.11%. The stock has underperformed its sector by 5.03% today, and its delivery volume has significantly dropped by 54.55% compared to the 5-day average, indicating falling investor participation. In terms of returns, the stock has seen a 7.11% decline over the past week and a 3.10% decline over the past month, although it has performed positively year-to-date with a 12.06% increase. The stock is currently trading higher than its 100-day and 200-day moving averages but lower than its 5-day, 20-day, and 50-day moving averages, suggesting mixed momentum. In the broader market context, the Sensex has also faced a decline of 2.65% over the past week and 0.23% over the past month, indicating a challenging environment for stocks in general. However, Crop Life Science's recent ...

Read More

View All News